CA2060501A1 - Anhydrous oil-based liquid suspension for delivering a medicament - Google Patents

Anhydrous oil-based liquid suspension for delivering a medicament

Info

Publication number
CA2060501A1
CA2060501A1 CA002060501A CA2060501A CA2060501A1 CA 2060501 A1 CA2060501 A1 CA 2060501A1 CA 002060501 A CA002060501 A CA 002060501A CA 2060501 A CA2060501 A CA 2060501A CA 2060501 A1 CA2060501 A1 CA 2060501A1
Authority
CA
Canada
Prior art keywords
liquid suspension
oil
drug delivery
delivery system
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002060501A
Other languages
English (en)
French (fr)
Inventor
Akwete Adjei
Saul Borodkin
Richard B. Doyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2060501A1 publication Critical patent/CA2060501A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002060501A 1989-06-13 1990-06-08 Anhydrous oil-based liquid suspension for delivering a medicament Abandoned CA2060501A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36540989A 1989-06-13 1989-06-13
US365,409 1989-06-13

Publications (1)

Publication Number Publication Date
CA2060501A1 true CA2060501A1 (en) 1990-12-14

Family

ID=23438802

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002060501A Abandoned CA2060501A1 (en) 1989-06-13 1990-06-08 Anhydrous oil-based liquid suspension for delivering a medicament

Country Status (10)

Country Link
EP (1) EP0477289A4 (he)
JP (1) JPH04506216A (he)
KR (1) KR920702616A (he)
AU (1) AU639004B2 (he)
CA (1) CA2060501A1 (he)
GR (1) GR1001028B (he)
IE (1) IE902109A1 (he)
IL (1) IL94710A (he)
PT (1) PT94372A (he)
WO (1) WO1991008734A1 (he)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
JP2001240534A (ja) * 2000-02-29 2001-09-04 Bio Kagaku Kk 液状組成物
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
US20040202696A1 (en) * 2003-04-14 2004-10-14 Cts Chemical Industries Ltd. Administration form for veterinary use
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2238973A (en) * 1940-07-26 1941-04-22 American Cyanamid Co Sulphonamide compound in oil
US2951014A (en) * 1957-01-03 1960-08-30 Upjohn Co Process for a stable oil suspension
US2867565A (en) * 1957-08-12 1959-01-06 Feinstone Wolffe Harry Sulfonamide composition comprising a lipid-aqueous emulsion carrier
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
IL87483A (en) * 1987-09-14 1993-07-08 Abbott Lab Anhydrous oil-based liquid suspension for delivering clorazepate dipotassium or estazolam

Also Published As

Publication number Publication date
EP0477289A4 (en) 1992-07-22
KR920702616A (ko) 1992-10-06
IE902109L (en) 1990-12-13
IL94710A0 (en) 1991-04-15
IL94710A (he) 1995-05-26
AU5934290A (en) 1991-07-18
AU639004B2 (en) 1993-07-15
IE902109A1 (en) 1991-01-02
GR1001028B (el) 1993-03-31
WO1991008734A1 (en) 1991-06-27
JPH04506216A (ja) 1992-10-29
GR900100441A (en) 1991-11-15
EP0477289A1 (en) 1992-04-01
PT94372A (pt) 1991-02-08

Similar Documents

Publication Publication Date Title
EP0701434B1 (en) Preparations containing silicon dioxide to improve the taste thereof
CA2019863C (en) Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
ES2414084T3 (es) Sistema de administración de fármacos por vía transmucosa
US5827536A (en) Pharmaceutical dosage formulations of fenofibrate and their applications
CA2800235C (en) Rifaximin ready-to-use suspension
US6221391B1 (en) Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
JP3022952B2 (ja) フラボノイド類を経口投与するための薬学的組成物
EP0556057A1 (en) Aqueous pharmaceutical suspension for pharmaceutical actives
EP0620001A1 (en) Aqueous pharmaceutical suspension and process for preparation thereof
US5730997A (en) Tastemasked liquid pharmaceutical delivery system
KR20050044590A (ko) 코팅된 미립자 세푸록심 악세틸 조성물
JP3774975B2 (ja) ゲル状徐放性組成物
Kimura et al. Pharmaceutical evaluation of ibuprofen fast‐absorbed syrup containing low‐molecular‐weight gelatin
CA2060501A1 (en) Anhydrous oil-based liquid suspension for delivering a medicament
EP0310801A1 (en) Anhydrous oil-based liquid suspension for delivering a medicament
JPH09504293A (ja) マグネシウムアルミニウムシリケート及び複数の活性成分を含有した速溶解性剤形
EP0422290A1 (en) Novel drug delivery system
JP2001106641A (ja) 口内薬
WO2011107617A1 (es) Composición farmacéutica líquida de ibuprofeno y codeína para su administración por vía oral, su procedimiento de preparación y utilización de la misma
WO1996006631A1 (en) Vancomycin hydrochloride suspensions for peroral use and for filling into soft gelatin capsules
JPS647967B2 (he)
JPS59106418A (ja) ニフエジピン製剤
HRP990030A2 (en) Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
IE893287A1 (en) Novel drug delivery system
JPH03153623A (ja) 新規な薬物輸送系

Legal Events

Date Code Title Description
FZDE Discontinued